Metraipolis › archive › dc_969bc2ccb009

Risk factors, severity-related factors, and clinical outcomes of immune checkpoint inhibitor-associated pneumonitis in elderly patients with lung cancer — Europe PMC PMID:42755748

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42755748
DOI: 10.3389/fonc.2026.1944973
License (as archived): solo-consultazione
Archived: 2026-10-16T03:53:02.731Z
SHA-256 of the archived text: 84fce0174e26bd57577944cf522c7b72e308ebd039fb89033e1e85294d350965
Stable URL of this page: https://metraipolis.com/documento/dc_969bc2ccb009

How to cite

Risk factors, severity-related factors, and clinical outcomes of immune checkpoint inhibitor-associated pneumonitis in elderly patients with lung cancer — Europe PMC PMID:42755748 — Europe PMC (en), https://europepmc.org/article/MED/42755748 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_969bc2ccb009 (Metraipolis archive dc_969bc2ccb009, sha256 84fce0174e26bd57577944cf522c7b72e308ebd039fb89033e1e85294d350965)

BibTeX

@misc{dc969bc2ccb009,
  title = {Risk factors, severity-related factors, and clinical outcomes of immune checkpoint inhibitor-associated pneumonitis in elderly patients with lung cancer — Europe PMC PMID:42755748},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42755748},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_969bc2ccb009; sha256 84fce0174e26bd57577944cf522c7b72e308ebd039fb89033e1e85294d350965},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42755748. Agents can read the archived copy with the MCP tool read_document.